View in EDS HTML Full Text PDF Full Text

Advancing pancreatic cancer therapy by mesothelin-specific nanobody conjugation.

Saved in:
Bibliographic Details
Title: Advancing pancreatic cancer therapy by mesothelin-specific nanobody conjugation.
Authors: Yi, Soyeon1 (AUTHOR), Noh, Kyunghee1,2 (AUTHOR), Kim, Hyeran1 (AUTHOR), Jung, Eunkyeong1 (AUTHOR), Kim, Suhyeon1,3 (AUTHOR), Lee, Jieun1 (AUTHOR), Guk, Kyeonghye1 (AUTHOR), Choi, Jinsol1,4 (AUTHOR), Lim, Eun-Kyung1,2,5 (AUTHOR), Kim, Seokho6 (AUTHOR), Park, Hwangseo7 (AUTHOR), Lim, Jung Hwa8,9 (AUTHOR), Jung, Cho-Rok8,9 (AUTHOR), Kang, Taejoon1,5 (AUTHOR), Jung, Juyeon1,2,5 (AUTHOR) jjung@kribb.re.kr
Source: Molecular Cancer. 4/24/2025, Vol. 24 Issue 1, p1-17. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14764598
DOI:10.1186/s12943-025-02325-7